SCHEMBL1908555

SCHEMBL1908555

CCc1cccc(C(C)(C)CO)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 3/20 0.44
▸ CNR1 P21554 1/20 0.41
▸ CNR2 P34972 1/20 0.41
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ BCL2 P10415 1/20 0.39
▸ TRPA1 O75762 1/20 0.38
▸ HTR2A P28223 2/20 0.37
▸ HTR2B P41595 2/20 0.37
▸ MGLL Q99685 1/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ CYP2A6 P11509 1/20 0.36
▸ ACP3 P15309 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15045357 0.85 CNR1 (0.47) CNR1CNR2CYP1A2CYP2C19LMNA
SCHEMBL1908507 0.85 ENPP2 (0.47) KIF11CNR1CNR2CYP1A2CYP2C19
SCHEMBL15504962 0.85 MEN1 (0.40) KIF11CNR1CNR2CYP1A2CYP2C19
SCHEMBL11066480 0.83 KIF11 (0.46) KIF11CYP1A2CYP2C19TP53BCL2
SCHEMBL30288253 0.82 TAAR1 (0.59) KIF11CYP1A2CYP2C19HTR2AHTR2C
SCHEMBL11546915 0.80 KIF11 (0.47) KIF11CNR1CNR2CYP1A2CYP2C19
SCHEMBL21277730 0.80 TAAR1 (0.57) KIF11CYP1A2CYP2C19TP53HTR2A
SCHEMBL23773724 0.79 HDAC8 (0.47) KIF11CNR1CNR2MAPTMEN1
SCHEMBL129592 0.79 KIF11 (0.46) KIF11CYP1A2CYP2C19TP53BCL2
SCHEMBL1653927 0.79 KIF11 (0.49) KIF11CYP1A2CYP2C19TP53HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093406-B2 Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors NOVARTIS AG (CH) 2012-01-10 — — US disclosed
Send feedback